Jonathan York (Past Speaker)

Dr. York is Vice President, Global Business Development, Daiichi Sankyo Group and leads the Oncology Transactions team responsible for identification, evaluation and negotiation of all Oncology BD and Licensing opportunities. Dr. York received his B.A. in Biology from the University of Pennsylvania, his M.D. from Boston University and his MBA from the Stern School of New York University. He completed residency training in Internal Medicine and Emergency Medicine at the Albert Einstein College of Medicine. He began his healthcare career in Emergency Medicine as a Director of Emergency Services for several hospitals in the N.Y Metro area. Previously he was a Managing Director at Foundation Ventures, a boutique Life Sciences investment and merchant banking firm focused on the venture capital market. Over the past decade at Daiichi Sankyo his responsibilities have included New Product Planning and US Business Development where he and his team supported the Company’s Oncology, Pain and Immunology portfolios.  In his current role he is a member of the Senior Licensing Committee and works directly with Daiichi Sankyo’s Cancer Enterprise and global senior management on acquisition, licensing, and research and development collaboration projects. Daiichi Sankyo research and development is primarily focused on bringing forth novel therapies in oncology, including immuno-oncology, with additional focus on new horizon areas, such as pain management, neurodegenerative diseases, heart and kidney diseases and other rare diseases.